TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
RSA Biomedical AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
4,689
|
4,600
|
5,574 |
| Financial expenses |
1
|
2
|
3 |
| Earnings before taxes |
2,797
|
1,865
|
2,423 |
| EBITDA |
2,259
|
1,932
|
2,499 |
| Total assets |
5,102
|
3,802
|
4,054 |
| Current assets |
4,829
|
3,477
|
3,646 |
| Current liabilities |
1,371
|
1,453
|
1,742 |
| Equity capital |
3,370
|
2,106
|
2,169 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
66.1%
|
55.4%
|
53.5% |
| Turnover per employee |
2,344
|
2,300
|
2,787 |
| Profit as a percentage of turnover |
59.7%
|
40.5%
|
43.5% |
| Return on assets (ROA) |
54.8%
|
49.1%
|
59.8% |
| Current ratio |
352.2%
|
239.3%
|
209.3% |
| Return on equity (ROE) |
83.0%
|
88.6%
|
111.7% |
| Change turnover |
-237
|
-807
|
-68 |
| Change turnover % |
-5%
|
-15%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.